CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) had Lessee, Operating Lease, Liability, to be Paid, Year One of $80.71 million as of 2025-12-27, per its 10-K filed 2026-02-18.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-02-18
- 2025-12-27: Lessee, Operating Lease, Liability, to be Paid, Year One $80.71M.
- 2024-12-28: Lessee, Operating Lease, Liability, to be Paid, Year One $77.88M.
- 2023-12-30: Lessee, Operating Lease, Liability, to be Paid, Year One $70.58M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $60.15M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2025-12-27 | $80.71M 10-K · filed 2026-02-18 |
| 2024-12-28 | $77.88M 10-K · filed 2025-02-19 |
| 2023-12-30 | $70.58M 10-K · filed 2024-02-14 |
| 2022-12-31 | $60.15M 10-K · filed 2023-02-22 |
| 2021-12-25 | $43.42M 10-K · filed 2022-02-16 |
| 2021-09-25 | $41.92M 10-Q · filed 2021-11-03 |
| 2021-06-26 | $39.98M 10-Q · filed 2021-08-04 |
| 2021-03-27 | $30.66M 10-Q · filed 2021-05-04 |
| 2020-12-26 | $31.33M 10-K · filed 2021-02-17 |
| 2020-09-26 | $30.70M 10-Q · filed 2020-10-29 |
| 2020-06-27 | $29.82M 10-Q · filed 2020-08-05 |
| 2019-12-28 | $25.95M 10-K · filed 2020-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |